Home › Funds › FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. › GILD
FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. position in GILD
GILEAD SCIENCES INC · Health Care
FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. reported holding 209,283 shares of GILD (GILEAD SCIENCES INC) in its Q3 2026 13F filing — a position valued at US$31.2M, representing 0.89% of its reported portfolio and ranking #19 among its reported holdings. FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. has disclosed GILD holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-10-22 · Source: SEC EDGAR Form 13F-HR
How FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A.'s GILD position evolved
FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. first disclosed a stake in GILD in Q4 2025 at 413,875 shares (US$50.8M). Across 4 filings, FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 209,283 shares valued at US$31.2M — an increase of 60,694 shares quarter over quarter.. Notable position changes include a 40% trim in Q1 2026 (shares fell 10% over the following quarter), a 40% trim in Q2 2026 (shares rose 18% over the following quarter), a 41% increase in Q3 2026 (shares rose 15% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 413.88K | $50.80M | New |
| Q1 2026 | 247.72K | $34.52M | Reduce |
| Q2 2026 | 148.59K | $18.77M | Reduce |
| Q3 2026 | 209.28K | $31.19M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GILD and 13F data
GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GILD
- Fidelity Management & Research (FMR) 66.87M sh · $8.45B · Q2 2026
- Capital World Investors 40.99M sh · $5.18B · Q2 2026
- Capital World Investors 40.99M sh · $5.18B · Q2 2026
- Invesco Ltd 39.82M sh · $5.03B · Q2 2026
- PRICE T ROWE ASSOCIATES INC /MD/ 30.00M sh · $3.79B · Q2 2026
- Dodge & Cox 23.68M sh · $2.99B · Q2 2026
- DODGE & COX 23.68M sh · $2.99B · Q2 2026
More on FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A.
FAQ
How long has FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. held GILD?
FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. has disclosed GILD holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A.'s current position in GILD?
As of Q3 2026, FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. holds 209.28K shares of GILD (GILEAD SCIENCES INC), valued at $31.19M, representing 0.89% of its reported portfolio and ranking #19.
Has FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. been buying or selling GILD?
In the latest 13F filing (Q3 2026), FIDEURAM - INTESA SANPAOLO PRIVATE BANKING S.P.A. increased its position in GILD.
Which other funds hold GILD?
Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.